Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application

• DOI: 10.1038/s41392-020-0177-z
• Publication Date: 2020-06-04T23:04:14Z
• Authors: Afsaneh Sadremomtaz; Ameena M. Ali; Foroozan Jouyandeh; Saeed Balalaie; Razieh Navari; Sylvain Broussy; Kamran Mansouri; Matthew R. Groves; S. Mohsen Asghari
• Keywords: Molecular Docking Simulation; Vascular Endothelial Growth Factor A; 0301 basic medicine; Vascular Endothelial Growth Factor B; 03 medical and health sciences; Letter; Vascular Endothelial Growth Factor Receptor-1; Neovascularization, Pathologic; Humans; Angiogenesis Inhibitors; Peptides